What's really ailing Citigroup


Oppenheimer & Co. managing director Meredith Whitney rose to fame with her presciently bearish analysis of Citigroup (NYSE: C) in October of 2007. Given that she's one of the few people who essentially predicted this entire debacle, she's probably worth listening to. Here's what she said in a note to investors on Citi's fourth quarter 2008 earnings. Pay close attention because it's a highly complex and nuanced argument:

C's core problem is that it simply doesn't make money in any of its businesses except Smith Barney, which it is in the process of selling.


You hear that federal government? Now stop plowing money into this train wreck!

If Meredith Whitney is right, Citigroup's stock is still overvalued: A company facing huge losses and no way of making money can't really justify a $15 billion market cap, can it?

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-14.8312,869.12
NASDAQ+2.462,918.32
S&P 500-1.121,348.84

Last updated: February 09, 2012: 11:54 AM

Hot Stocks

General Electric

19.125-0.115(-0.60)

Alcoa

10.60-0.07(-0.66)

Apple Inc

492.68+16.00(+3.36)

Google Inc 'A'

610.03+0.18(+0.03)

Bank of America

8.145+0.015(+0.18)

Wal-Mart Stores

61.76+0.14(+0.23)

Exxon Mobil Corp

84.71-0.61(-0.72)

Ford

12.70-0.14(-1.09)

Citigroup

33.93-0.30(-0.88)

IBM

192.67-0.28(-0.15)

Yahoo

15.955+0.175(+1.11)

Starbucks

48.95+0.23(+0.47)

Microsoft

30.57-0.09(-0.29)

Home Depot

44.895-0.275(-0.61)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328806489949 ms.